Page 15 - CCV-AR-2015-MASTER.indd
P. 15
Dube E, Vivion M, MacDonald NE. Th e infl uence Herder M, Hatchette T, Halperin S, Langley
of the anti-vaccine movement on parental vaccine J. Against vaccine assay secrecy. Human
decisions: clinical impact and future challenges. Expert VaccineImmunother (2014) 11: 498-503
Rev Vaccines (2014) 14: 99-117.
Herder M, Gibson E, Graham JE, Lexchin J, Mintzes
Falsey AR, McElhaney JE, Beran J, van Essen GA, B. Regulating prescription drugs for patient safety:
Duval X, Esen M, Galtier F, Gervais P, Hwang SJ, Does Bill C-17 go far enough? CMAJ (2014) 186: 287-
Kremsner P, Launay O, Leroux-Roels G, McNeil SA, 292.
Nowakowski A, Richardus JH, Ruiz-Palacios G, St
Rose S, Devaster JM, Oostvogels L, Durviaux S, Taylor
S. Respiratory syncytial virus and other respiratory Ho T-S., Lin C-F., Liu C-C., Ye T-M, Anderson R. and
viral infections in older adults with moderate to severe Lin YS. Lessons learned from dengue: focus on Taiwan.
infl uenza-like illness. J Infect Dis (2014) 209: 1873-81. in Dengue: transmission, diagnosis and surveillance,
J. Whitehorn and J. Farrar, eds, Future Medicine;
Clinical Insights, ebook (2014) pp. 49-64.
Fang YT, Wan SW, Lu YT, Yao JH, Lin CF, Hsu
LJ, Brown MG, Marshall JS, Anderson R, Lin YS.
Autophagy facilitates antibody-enhanced dengue virus Junkins RD, McCormick C, Lin TJ. Th e emerging
infection in human pre-basophil/mast cells. PLoS One potential of autophagy-based therapies in the treatment
(2014) 9: e110655. of cystic fi brosis lung infections. Autophagy (2014) 10:
538–547.
Fell DB, Dodds L, McNeil S, MacDonald NE. H1N1
infl uenza vaccination during pregnancy. BMJ (2014) Karkada M, Berinstein NL, Mansour M. Th erapeutic
348: g3500. vaccines and cancer: focus on DPX-0907. Biologics
(2014) 8: 27-38.
Halperin BA, MacKinnon-Cameron D, Math M,
McNeil S, Kalil J, Halperin SA. Maintaining the Key T, Duncan R. A compact multifunctional
momentum: Key factors infl uencing acceptance fusion module directs cholesterol-dependent
of infl uenza vaccination among pregnant women homomultimerization and syncytiogenic effi ciency of
following the H1N1 pandemic. Human Vaccines reovirus p10 FAST proteins. PLoS Pathogens (2014) 10:
Immunother. (2014) 10: 3629-3641. e100402.
Halperin SA, Baine Y, Domachowske JB, Aggarwal Khaperskyy DA, Emara MM, Johnston BP, Anderson
N, Simon M, Langley JM, McNeil SA, Friedland L. P, Hatchette TF , McCormick C. Infl uenza A
R, Bianco V, Baccarini CI, Miller JM. Comparison of virus host shutoff disables antiviral stress-induced
the safety and immunogenicity of a novel quadrivalent translation arrest. PLoS Pathogens (2014) 10: e1004217.
meningococcal ACWY-tetanus toxoid conjugate
vaccine and a marketed quadrivalent meninogococcal
ACWY-diphtheria toxoid conjugate vaccine in healthy Krajden M, Cook D, Yu A, Chow R, Su Q, Mei
individuals 10-25 years of age. J Ped Infect Dis (2014) 3: W, McNeil SA, Money D, Dionne M, Palefsky J,
33-42. Karunakaran K, Kollmann T, Ogilvie G, Petric M,
Dobson S. Assessment of HPV 16 and HPV 18 antibody
responses by pseudovirus neutralization, Merck cLIA
Hatchette TF , Davis I, Johnston BL. Lyme Disease; and Merck total IgG LIA immunoassays in a reduced
Clinical Diagnosis and Treatment. CCDR (2014) 40: dosage quadrivalent HPV vaccine trial. Vaccine (2014)
194-209. 32: 624-30.
13
Annual Report | 2014-15
of the anti-vaccine movement on parental vaccine J. Against vaccine assay secrecy. Human
decisions: clinical impact and future challenges. Expert VaccineImmunother (2014) 11: 498-503
Rev Vaccines (2014) 14: 99-117.
Herder M, Gibson E, Graham JE, Lexchin J, Mintzes
Falsey AR, McElhaney JE, Beran J, van Essen GA, B. Regulating prescription drugs for patient safety:
Duval X, Esen M, Galtier F, Gervais P, Hwang SJ, Does Bill C-17 go far enough? CMAJ (2014) 186: 287-
Kremsner P, Launay O, Leroux-Roels G, McNeil SA, 292.
Nowakowski A, Richardus JH, Ruiz-Palacios G, St
Rose S, Devaster JM, Oostvogels L, Durviaux S, Taylor
S. Respiratory syncytial virus and other respiratory Ho T-S., Lin C-F., Liu C-C., Ye T-M, Anderson R. and
viral infections in older adults with moderate to severe Lin YS. Lessons learned from dengue: focus on Taiwan.
infl uenza-like illness. J Infect Dis (2014) 209: 1873-81. in Dengue: transmission, diagnosis and surveillance,
J. Whitehorn and J. Farrar, eds, Future Medicine;
Clinical Insights, ebook (2014) pp. 49-64.
Fang YT, Wan SW, Lu YT, Yao JH, Lin CF, Hsu
LJ, Brown MG, Marshall JS, Anderson R, Lin YS.
Autophagy facilitates antibody-enhanced dengue virus Junkins RD, McCormick C, Lin TJ. Th e emerging
infection in human pre-basophil/mast cells. PLoS One potential of autophagy-based therapies in the treatment
(2014) 9: e110655. of cystic fi brosis lung infections. Autophagy (2014) 10:
538–547.
Fell DB, Dodds L, McNeil S, MacDonald NE. H1N1
infl uenza vaccination during pregnancy. BMJ (2014) Karkada M, Berinstein NL, Mansour M. Th erapeutic
348: g3500. vaccines and cancer: focus on DPX-0907. Biologics
(2014) 8: 27-38.
Halperin BA, MacKinnon-Cameron D, Math M,
McNeil S, Kalil J, Halperin SA. Maintaining the Key T, Duncan R. A compact multifunctional
momentum: Key factors infl uencing acceptance fusion module directs cholesterol-dependent
of infl uenza vaccination among pregnant women homomultimerization and syncytiogenic effi ciency of
following the H1N1 pandemic. Human Vaccines reovirus p10 FAST proteins. PLoS Pathogens (2014) 10:
Immunother. (2014) 10: 3629-3641. e100402.
Halperin SA, Baine Y, Domachowske JB, Aggarwal Khaperskyy DA, Emara MM, Johnston BP, Anderson
N, Simon M, Langley JM, McNeil SA, Friedland L. P, Hatchette TF , McCormick C. Infl uenza A
R, Bianco V, Baccarini CI, Miller JM. Comparison of virus host shutoff disables antiviral stress-induced
the safety and immunogenicity of a novel quadrivalent translation arrest. PLoS Pathogens (2014) 10: e1004217.
meningococcal ACWY-tetanus toxoid conjugate
vaccine and a marketed quadrivalent meninogococcal
ACWY-diphtheria toxoid conjugate vaccine in healthy Krajden M, Cook D, Yu A, Chow R, Su Q, Mei
individuals 10-25 years of age. J Ped Infect Dis (2014) 3: W, McNeil SA, Money D, Dionne M, Palefsky J,
33-42. Karunakaran K, Kollmann T, Ogilvie G, Petric M,
Dobson S. Assessment of HPV 16 and HPV 18 antibody
responses by pseudovirus neutralization, Merck cLIA
Hatchette TF , Davis I, Johnston BL. Lyme Disease; and Merck total IgG LIA immunoassays in a reduced
Clinical Diagnosis and Treatment. CCDR (2014) 40: dosage quadrivalent HPV vaccine trial. Vaccine (2014)
194-209. 32: 624-30.
13
Annual Report | 2014-15
